Reinhard Ziegler

Reinhard Ziegler's AcademicInfluence.com Rankings

Reinhard Ziegler

Philosophy

#7086

World Rank

#10247

Historical Rank

Ontology

#72

World Rank

#82

Historical Rank

Logic

#4162

World Rank

#5420

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Reinhard Ziegler's Degrees

PhD Biomedical Sciences University of California, San Francisco
Doctorate Medicine Stanford University

Why Is Reinhard Ziegler Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Reinhard Ziegler's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. (1994) (540)
AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. (1998) (540)
Reduced Pulmonary Function in Patients with Spinal Osteoporotic Fractures (1998) (496)
Role of NFkappaB in the mortality of sepsis. (1997) (449)
Advanced Glycation End Product-Induced Activation of NF-κB is Suppressed by α-Lipoic Acid in Cultured Endothelial Cells (1997) (359)
Tumor necrosis factor increases serum leptin levels in humans. (1997) (274)
Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. (2001) (262)
Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study (2001) (258)
Seasonal variation of biochemical indexes of bone turnover: results of a population-based study. (1998) (251)
Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. (1997) (245)
A newly developed spine deformity index (SDI) to quantitate vertebral crush fractures in patients with osteoporosis. (1988) (238)
Stimulation of bone matrix apposition in vitro by local growth factors: a comparison between insulin-like growth factor I, platelet-derived growth factor, and transforming growth factor beta. (1990) (224)
Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption (1996) (202)
Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies. (1996) (196)
Hyperhomocyst(e)inemia and Endothelial Dysfunction in IDDM (1997) (193)
Gonadal and Adrenal Androgens Are Potent Regulators of Human Bone Cell Metabolism In Vitro (1997) (193)
Clinical Grading of Spinal Osteoporosis: Quality of Life Components and Spinal Deformity in Women with Chronic Low Back Pain and Women with Vertebral Osteoporosis (1997) (189)
A study of complaints and their relation to vertebral destruction in patients with osteoporosis. (1990) (187)
Diabetes mellitus a risk for osteoporosis? (2001) (185)
Outcome of bone mineral density in anorexia nervosa patients 11.7 years after first admission (1993) (181)
Novel Serum Markers of Bone Resorption: Clinical Assessment and Comparison with Established Urinary Indices (1999) (180)
Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kB (1999) (176)
Mitogenic responsiveness of human bone cells in vitro to hormones and growth factors decreases with age (1993) (172)
Chemotactic response of osteoblastlike cells to transforming growth factorβ (1990) (171)
Activation of tubular epithelial cells in diabetic nephropathy. (2002) (164)
alpha-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. (1999) (158)
Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women. (1996) (152)
Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone. (1995) (150)
Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. (1995) (139)
Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. (2001) (131)
Prognostic value of codon 918 (ATG→ACG) RET proto‐oncogene mutations in sporadic medullary thyroid carcinoma (2001) (126)
17 beta-estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages. (1990) (125)
Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. (1997) (122)
Skeletal Site-Dependent Expression of the Androgen Receptor in Human Osteoblastic Cell Populations (1997) (118)
Decreased serum levels of insulin‐like growth factors and IGF binding protein 3 in osteoporosis (1993) (118)
Circannual Rhythms and Interactions of Vitamin D Metabolites, Parathyroid Hormone, and Biochemical Markers of Skeletal Homeostasis: A Prospective Study (2000) (117)
Mechanism of the Tumor Necrosis Factor α-mediated Induction of Endothelial Tissue Factor (*) (1995) (116)
Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. (2001) (115)
Human bone cell phenotypes differ depending on their skeletal site of origin. (1995) (114)
Role of NF k B in the Mortality of Sepsis (1997) (112)
Lower serum 25-hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females: a population-based study. (2009) (109)
Changes in Bone Turnover Induced by Aerobic and Anaerobic Exercise in Young Males (1998) (107)
Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease. (1996) (105)
Hypercalcemic crisis. (2001) (101)
Inflammation-mediated osteopenia in the rat: a new animal model for pathological loss of bone mass. (1984) (100)
Comparison of total and bone-specific alkaline phosphatase in patients with nonskeletal disorder or metabolic bone diseases. (1996) (100)
What is a vertebral fracture? (1996) (96)
Endothelin-1 Is a Potent Regulator of Human Bone Cell Metabolism In Vitro (1997) (87)
Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patients. (1994) (86)
Association of Transforming Growth Factor-b1 (TGFb1) T29?C Gene Polymorphism with Bone Mineral Density (BMD), Changes in BMD, and Serum Concentrations of TGF-b1 in a Population-Based Sample of Postmenopausal German Women (2001) (86)
Urinary hydroxypyridinium crosslinks of collagen in population‐based screening for overt vertebral osteoporosis: Results of a pilot study (1994) (85)
Bone disease after liver transplantation. (1992) (85)
Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity. (1998) (84)
Differential regulation of plasminogen activator and plasminogen activator inhibitor by osteotropic factors in primary cultures of mature osteoblasts and osteoblast precursors. (1990) (83)
Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre- and postmenopausal women: relationship to age, menopause, bone turnover, bone volume, and circulating IGFs. (1998) (82)
A systemic acceleratory phenomenon (SAP) accompanies the regional acceleratory phenomenon (RAP) during healing of a bone defect in the rat (1991) (82)
Vascular origin of Kaposi's sarcoma. Expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor. (1994) (82)
Sex Difference in the Validity of Vertebral Deformities as an Index of Prevalent Vertebral Osteoporotic Fractures: A Population Survey of Older Men and Women (2000) (74)
Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,25-dihydroxyvitamin D3. (1990) (73)
sn-1,2-Diacylglycerols and phorbol diesters stimulate thromboxane synthesis by de novo synthesis of prostaglandin H synthase in human promyelocytic leukemia cells. (1987) (70)
Influence of Inflammation-Mediated Osteopenia on the Regional Acceleratory Phenomenon and the Systemic Acceleratory Phenomenon During Healing of a Bone Defect in the Rat (1998) (69)
Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy. (1993) (69)
Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization. (1992) (67)
[Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: need for additional growth hormone substitution?]. (1991) (64)
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. (2009) (64)
Effects of fluoride on rat vertebral body biomechanical competence and bone mass. (1995) (63)
Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse meth-A sarcoma. (1996) (63)
Forearm BMD as measured by peripheral quantitative computed tomography (pQCT) in a German reference population (1994) (62)
Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation (2003) (62)
Effects of angiotensin II on bone cells in vitro (1998) (62)
Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. (1999) (60)
Combination chemotherapy of advanced medullary and differentiated thyroid cancer (2005) (60)
Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis). (2009) (60)
Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma. (1989) (59)
Glucocorticoid-induced Osteoporosis: Prevention and Treatment (1998) (58)
Effect of clodronate treatment on bone scintigraphy in metastatic breast cancer. (1993) (57)
Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly. (1991) (57)
Antiestrogen and antiandrogen administration reduce bone mass in the rat. (1989) (53)
Smoking influences the atherogenic potential of low-density lipoprotein (1992) (53)
Ultrasound Measurements at the Proximal Phalanges in Healthy Women and Patients with Hip Fractures (1998) (53)
Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma (2001) (52)
Alteration of plasma low density lipoprotein from smokers. (1990) (52)
The hypercalcaemic syndrome in rats bearing the Walker carcinosarcoma 256. (1975) (47)
Molecular cloning of genes differentially regulated by TNF-alpha in bovine aortic endothelial cells, fibroblasts and smooth muscle cells. (1998) (47)
Bone mass of spine and forearm in osteoporosis and in German normals: influences of sex, age and anthropometric parameters (1992) (45)
Transforming growth factor β (TGF-β) levels in the conditioned media of human bone cells: relationship to donor age, bone volume, and concentration of TGF-β in human bone matrix in vivo (1999) (45)
A case of neuroendocrine oncogenic osteomalacia associated with a PHEX and fibroblast growth factor-23 expressing sinusidal malignant schwannoma. (2001) (45)
Localisation of protein Z in vascular lesions of patients with atherosclerosis. (1998) (44)
Postmenopausal hormone replacement therapy and the vascular wall: mechanisms of 17 beta-estradiol's effects on vascular biology. (2009) (44)
Elevated Thrombomodulin Plasma Levels as a Result of Endothelial Involvement in Plasmodium falciparum Malaria (1994) (44)
Improved purification of human bone sialoprotein and development of a homologous radioimmunoassay. (1997) (42)
mRNA expression profiles for corticotrophin-releasing hormone, urocortin, CRH-binding protein and CRH receptors in human term gestational tissues determined by real-time quantitative RT-PCR. (2004) (41)
Glucocorticoids Regulate the Expression of the Human Osteoblastic Endothelin A Receptor Gene (1998) (40)
Serum parathyroid hormone, but not menopausal status, is associated with the expression of osteoprotegerin and RANKL mRNA in human bone samples. (2001) (40)
Diagnosis and management of pheochromocytomas in patients with multiple endocrine neoplasia type 2-relevance of specific mutations in the RET proto-oncogene. (1996) (40)
Papillary carcinoma in an ectopic thyroid. (1991) (39)
Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin. (2009) (38)
Serum levels of intact parathyroid hormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism. (1992) (38)
Short- and long-term effects of ibandronate treatment on bone turnover in Paget disease of bone. (2000) (38)
Pregnancy in persistent acromegaly (2000) (37)
Effects of 6 years of growth hormone (GH) treatment on bone mineral density in GH‐deficient adults (2001) (37)
Quality of life and vertebral osteoporosis (1992) (36)
Clinical significance of antibodies against calcitonin. (2009) (36)
Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus. (1996) (36)
Comparison of a semiquantitative and a quantitative method for assessing vertebral fractures in osteoporosis (1994) (34)
Cell specific effects of glucocorticoid treatment on the NF-kappaBp65/IkappaBalpha system in patients with Crohn's disease. (1999) (34)
Inhibition of phosphoenolpyruvate carboxykinase gene expression by metformin in cultured hepatocytes. (2002) (34)
Regulation of interleukin-6 expression in human osteoblastic cells in vitro. (2009) (33)
Pathophysiology of osteoporosis: unresolved problems and new insights. (1995) (33)
Low serum concentrations of insulin‐like growth factor I are associated with femoral bone loss in a population‐based sample of postmenopausal women (2001) (33)
Differential effects of platelet-derived growth factor isoforms on plasminogen activator activity in fetal rat osteoblasts due to isoform-specific receptor functions. (1992) (33)
The secretion of calcitonin by the perfused ultimobranchial gland of the hen. (1969) (32)
Differentiation of binding sites on reconstituted hepatic scavenger receptors using oxidized low-density lipoprotein. (1992) (32)
Reversible diminished calcitonin secretion in the rat during chronic hypercalcemia. (1984) (32)
The antioxidant properties of thioctic acid: Characterization by cyclic voltammetry (1997) (32)
The effect of pramlintide (amylin analogue) treatment on bone metabolism and bone density in patients with type 1 diabetes mellitus. (1999) (32)
Circulating levels of midregional parathyroid hormone‐related protein in hypercalcaemia of malignancy (1992) (32)
Ibandronate treatment in Paget's disease of bone. (1999) (31)
Leptin concentrations in serum from a randomly recruited sample of 50- to 80-year-old men and women: positive association with plasma insulin-like growth factors (IGFs) and IGF-binding protein-3 in lean, but not in obese, individuals. (1998) (31)
Age-related changes in insulin-like growth factor I and II in human femoral cortical bone: lack of correlation with bone mass. (1999) (31)
In vitro detection of neutralizing antibodies after treatment of paget's disease of bone with nasal salmon calcitonin (1990) (31)
Binding of acetylated low density lipoprotein and maleylated bovine serum albumin to the rat liver: one or two receptors? (1987) (31)
Measurement of Forearm Bone Mineral Density: Comparison of Precision of Five Different Instruments (1998) (30)
Transforming growth factor beta (TGF-beta) levels in the conditioned media of human bone cells: relationship to donor age, bone volume, and concentration of TGF-beta in human bone matrix in vivo. (1999) (30)
Severe Osteoporosis in Familial Hajdu–Cheney Syndrome: Progression of Acro‐Osteolysis and Osteoporosis During Long‐Term Follow‐up (1999) (29)
Effects of triiodothyronine on the insulin-like growth factor system in primary human osteoblastic cells in vitro. (2001) (29)
Diagnostic procedure before reoperation in patients with medullary thyroid carcinoma. (1989) (29)
Ultrasound transmission speed and ultrasound bone profile score (UBPS) of the phalanges in normal women and women with osteoporosis. (1998) (29)
Age-associated changes in the stimulatory effect of transforming growth factor beta on human osteogenic colony formation (1999) (29)
Effects of hypercalcemia, hypercalcemia and calcitonin on glucose stimulated insulin secretion in man. (1972) (28)
Octreotide (somatostatin analog) treatment reduces endothelial cell dysfunction in patients with diabetes mellitus. (1999) (28)
Sex Steroids and Bone (1994) (28)
Molecular Mechanisms of Diabetic Angiopathy – Clues for Innovative Therapeutic Interventions (1998) (27)
Effect of calcitonin on the regeneration of a circumscribed bone defect (bored hole in the rat tibia). (1972) (27)
Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and & epsilon;1/lsquo;null genotype‡ (1992) (27)
[Effect of pamidronate on clinical symptoms and bone metabolism in fibrous dysplasia and McCune-Albright syndrome]. (1998) (26)
Metformin modulates insulin post-receptor signaling transduction in chronically insulin-treated Hep G2 cells. (2003) (25)
The influences of acute hyper- and hypocalcemia and of calcitonin on exocrine pancreatic function in man (1973) (25)
Early reversible induction of leukotriene synthesis in chicken myelomonocytic cells transformed by a temperature-sensitive mutant of avian leukemia virus E26. (1989) (25)
The use of octreotide in the treatment of medullary thyroid carcinoma. (1993) (25)
Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volume. (1997) (24)
Automated and manual assays for urinary crosslinks of collagen: which assay to use? (2009) (23)
Effects of androgens on subpopulations of the human osteosarcoma cell line SaOS2 (1996) (23)
Neutralizing antibodies against calcitonin. (1993) (22)
Influence of ramipril on the course of plasma thrombomodulin in patients with diabetes mellitus. (1999) (22)
Benefits of growth hormone treatment on bone metabolism, bone density and bone strength in growth hormone deficiency and osteoporosis. (1998) (22)
Calcitonin and exocrine pancreatic secretion in man: inhibition of enzymes stimulated by CCK-pancreozymin, caerulein, or calcium—no response to vagal stimulation 12 (1977) (22)
[Therapy of the adrenocortical carcinoma with Lysodren (o,p'-DDD). Therapeutic management by monitoring o,p'-DDD blood levels]. (2001) (22)
1,25-Dihydroxyvitamin D3 prevents the decrease of bone mineral appositional rate in rats with inflammation-mediated osteopenia (IMO). (1989) (22)
Primary glucocorticoid receptor defect with likely familial involvement. (1989) (21)
Differential effects of glucocorticoids on human osteoblastic cell metabolism in vitro (1995) (21)
Parathyroid hormone and calcitonin: influences upon lipolysis of human adipose tissue. (1974) (21)
Retroperitoneal fibrosis in a patient with macroprolactinoma treated with bromocriptine. (1989) (21)
Antiparasitic Treatment of Patients with P. falciparum Malaria Reduces the Ability of Patient Serum to Induce Tissue Factor by Decreasing NF-κB Activation (1995) (21)
Lnterlaboratory comparison of radioimmunological parathyroid hormone determination* (1978) (20)
Rhythmic oscillations of cytosolic free calcium m rat C-cells (1989) (20)
Acute hypercalcemia due to Walker carcinosarcoma 256 in the rat. (1970) (20)
Cyclic AMP formation in rat bone and kidney cells is stimulated equally by parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34. (2009) (20)
[Non-enzymatic glycation and oxidative stress in chronic illnesses and diabetes mellitus]. (1999) (20)
[Thrombomodulin is a marker of microvascular, but not for macrovascular endothelial cell damage]. (1995) (20)
Down-regulation of calcitonin receptors in T47D cells by internalization of calcitonin-receptor complexes (1988) (19)
Paget's disease of bone in West Germany. Prevalence and distribution. (1985) (19)
Clinical features of type III hyperlipoproteinemia: analysis of 64 patients (1993) (19)
Apolipoprotein E phenotypes and hyperlipidemia in patients under maintenance hemodialysis (2004) (18)
Relationship between IGF-I and skeletal aging. (1998) (18)
Inflammation-mediated osteopenia (IMO) during acute inflammation in rats is due to a transient inhibition of bone formation (1987) (17)
Alteration of the Activity of the 11β-Hydroxysteroid Dehydrogenase in Pregnancy: Relevance for the Development of Pregnancy-Induced Hypertension? (2001) (17)
Concentrations of insulin-like growth factor (IGF)-I, -II, and IGF binding protein-4, and -5 in human bone cell conditioned medium do not change with age (2000) (17)
Formation of neutralizing antibodies after treatment with human calcitonin. (1993) (17)
[Therapy of hirsutism in females with adrenal enzyme defects of steroid hormone biosynthesis: comparison of dexamethasone with cyproterone acetate]. (1990) (17)
Positive association between circulating free thyroxine and insulin‐like growth factor I concentrations in euthyroid elderly individuals (1998) (17)
Binding characteristics of reduced hepatic receptors for acetylated low-density lipoprotein and maleylated bovine serum albumin. (1990) (17)
Inflammation-mediated osteopenia in the rat: the effects of artificial granuloma and sham operation on cortical and trabecular bone. (1985) (17)
Characterization of a feminizing testicular leydig cell tumor by hormonal profile, immunocytochemistry, and tissue culture (1985) (16)
Treatment of tumor hypercalcemia with clodronate. (1989) (16)
Long-term excess of endogenous calcitonin in patients with medullary thyroid carcinoma does not affect bone mineral density. (1992) (16)
Mineral apposition rate in rat cortical bone: Physiologic differences in different sites of the same tibia (1992) (16)
Differential effects of 1,25-dihydroxyvitamin D3 on cell proliferation and calcitonin gene expression. (1994) (16)
Radioimmunoassay for human parathyroid hormone for differentiation between patients with hypoparathyroidism, hyperparathyroidism and normals. (1979) (16)
Gynecomastia caused by estrogen containing hair lotion (1984) (16)
Hyperhomocyst(e)inemia and Endothelial Dysfunction in IDDM (1998) (15)
Expression of Interleukin-6 (IL-6) and IL-6 receptor mRNA in human bone samples from pre- and postmenopausal women. (2002) (15)
Calcitonin in human pathophysiology. (1984) (15)
Current therapy of hypoparathyroidism--a survey of German endocrinology centers. (2009) (15)
Expression of type III hyperlipoproteinaemia in a subject with secondary hypothyroidism bearing the apolipoprotein E2/2 phenotype (1991) (15)
Ultrasound velocity of the tibia in normal german women and hip fracture patients (1996) (14)
The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia (1992) (14)
Enhanced suppression of 1,25(OH)2D3 and intact parathyroid hormone in Graves' disease as compared to toxic nodular goiter (2007) (14)
Concentration of insulin-like growth factor (IGF)-I in iliac crest bone matrix in premenopausal women with idiopathic osteoporosis. (2004) (14)
[Prevalence of thyroid gland dysfunctions in 50- to 80-year-old patients. An epidemiologic cross-sectional study in a southwestern community]. (1997) (14)
Serum Calcium and Gastric Secretion in Chronic Gastric Fistula Rat: Influences of Parathyroid Hormone and Calcitonin (1971) (13)
Serum amyloid A protein (SAA): a marker for liver allograft rejection in humans (1994) (13)
Levels of parathyroid hormone-related protein (PTHrP) in hypercalcemia of malignancy are not lowered by treatment with the bisphosphonate BM 21.0955. (1993) (13)
(CA)(n) dinucleotide repeat polymorphism at the 5'-end of the aldose reductase gene is not associated with microangiopathy in Caucasians with long-term diabetes mellitus 1. (2000) (13)
Reduced bone mineral density and low parathyroid hormone levels in patients with the adult form of hypophosphatasia (1992) (13)
Osteolytic activity of Walker carcinosarcoma 256 is due to parathyroid hormone-related protein (PTHrP). (1991) (13)
Influence of fluor salts, hormone replacement therapy and calcitonin on the concentration of insulin-like growth factor (IGF)-I, IGF-II and transforming growth factor-beta 1 in human iliac crest bone matrix from patients with primary osteoporosis. (2004) (13)
BIOLOGICAL VARIABILITY OF SERUM IMMUNOREACTIVE BONE SIALOPROTEIN (1998) (12)
Intravenous glucose tolerance and insulin secretion in the rat after thyroidectomy. (2009) (12)
Tumor necrosis factor α inhibits the stimulatory effect of the parathyroid hormone-related protein on cyclic AMP formation in osteoblast-like cells via protein kinase C (1992) (12)
Reversible desensitization of calcitonin secretion by repetitive stimulation with calcium (1989) (12)
Glucocorticoids decrease the production of parathyroid hormone-related protein in vitro but not in vivo in the Walker carcinosarcoma 256 rat model. (1996) (12)
Inhibitory effect of somatostatin on cAMP accumulation and calcitonin secretion in C-cells: Involvement of pertussis toxin-sensitive G-proteins (1992) (11)
Persistent inhibition of gastric secretion by an intravenous 12-hour infusion of calcitonin in normals, peptic ulcer and high risk patients. (1974) (11)
Action of calcitonin gene-related peptide at the calcitonin receptor of the T47D cell line. (1987) (11)
Evaluation of sensitive PDN-21 (Katacalcin) determination as tumor marker in medullary thyroid carcinoma (1992) (11)
Tris(8-quinolinolato)gallium(III), a Novel Orally Applied Antitumor Gallium Compound (1999) (11)
Application of genetic screening in families with hereditary medullary thyroid carcinoma. (2009) (11)
Relation of cardiovascular risk factors to atherosclerosis in type III hyperlipoproteinemia (1993) (11)
Calcitonin: analgesic effects. (1984) (11)
Effects of passive immunization against parathyroid hormone‐related protein: PTHrP is the responsible factor in mediating hypercalcemia in the walker carcinosarcoma 256 rat model (1995) (11)
[Osteoporosis and cardiovascular disease--two sides of the same coin?]. (2003) (11)
The effect of chronic lithium application on the mineral content of rat bone and soft tissues. (1975) (11)
Bone loss in experimental diabetes. Comparison with the model of inflammation mediated osteopenia. (1993) (10)
[Hypercalcemic syndrome and hypercalcemic crisis. Symptoms, differential diagnosis and therapy]. (1973) (10)
Diabetes mellitus and bone metabolism. (1992) (10)
Comparative bone analysis via inflammation-mediated osteopenia (IMO) in the rat (1985) (10)
[Therapy of metastatic medullary thyroid gland carcinoma with the somatostatin analog octreotide]. (1995) (10)
[Epidemiology of hypercalcemia. Significance of the determination of intact parathyroid hormone for differential diagnosis]. (2008) (10)
1,25-Dihydroxyvitamin D3 suppresses dexamethasone effects on calcitonin secretion (1990) (10)
Inhibition of gastric secretion in man by oral administration of calcitonin. (1974) (10)
[Observations in vitamin D and dihydrotachysterol poisoning]. (1975) (9)
Does immobilization influence the systemic acceleratory phenomenon that accompanies local bone repair? (1992) (9)
Graves' ophthalmopathy, ocular myasthenia gravis and Hashimoto's thyroiditis. (1985) (9)
Inhibition of human gastric secretion by intragastrically administered calcitonin. (1980) (9)
Calciotropic hormones and lipolysis of human adipose tissue: role of extracellular calcium as conditioning but not regulating factor. (1980) (9)
[Fluoride therapy of osteoporosis]. (1976) (9)
Unresponsiveness of exocrine rat pancreas to calcemic challenges (hypercalcemia, EDTA hypocalcemia or calcitonin administration) which influence stomach function (1974) (9)
Acute effect of 1,25-dihydroxy-vitamin D3 on calcitonin secretion in rats. (1983) (9)
Identification of four genes in endothelial cells whose expression is affected by tumor cells and host immune status : A study in ex vivo-isolated endothelial cells (1998) (9)
Renal bone disorders in children: therapy with vitamin D3 or 1,25-dihydroxycholecalciferol. (1979) (9)
alpha-Tocopherol induces leptin expression in healthy individuals and in vitro. (1999) (9)
Effects of 17β‐estradiol on calcitonin secretion and content in a human medullary thyroid carcinoma cell line (1991) (9)
Comparion of serum angiotensin-converting enzyme in Graves' disease, toxic nodular goiter, and other thyroid conditions (1985) (8)
Inhibition of Ca(2+)-induced calcitonin secretion by somatostatin: roles of voltage dependent Ca2+ channels and G-proteins. (1992) (8)
Pancreatic enzyme secretion in the conscious rat (1975) (8)
Splenectomy in an uraemic patient with acquired factor X deficiency due to AL amyloidosis. (1998) (8)
[Estrogens and osteoporosis]. (1989) (8)
Effects of estrogen on the concentration of insulin-like growth factor-I in rat bone matrix. (1998) (8)
Pheochromocytoma in multiple endocrine neoplasia. (1985) (8)
[Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands]. (1985) (8)
Enhanced calcitonin secretion in the rat after parathyroidectomy and during chronic calcium deprivation (1988) (8)
Identification of four genes in endothelial cells whose expression is affected by tumor cells and host immune status--a study in ex vivo-isolated endothelial cells. (1998) (8)
Sporadic medullary thyroid carcinoma: clinical features and diagnosis. (1992) (8)
Mechanism of endothelial cell activation. (1993) (8)
[Successful use of a heparinoid (danaparoid sodium) for heparin-induced thrombocytopenia type II in aortic valve reoperation]. (1995) (8)
Internalization of calcitonin receptors in primary rat kidney cell cultures. (1990) (8)
[Multiple endocrine neoplasia associated with multiple lipomas]. (1998) (8)
[Primary hyperparathyroidism--changes in the disease picture]. (1989) (8)
Add-back medrogestone does not prevent bone loss in premenopausal women treated with goserelin. (2009) (7)
Hypoglycemia in diabetics. (1976) (7)
Superior local tolerability of human versus salmon calcitonin preparations in young healthy volunteers (2004) (7)
[Osteosonography of the phalanges of men]. (1998) (7)
[Hypercalcemic activity of Walker carcinosarcoma 256 in the rat]. (1971) (7)
Homologous desensitization of calcitonin receptors and calcitonin-dependent adenylate cyclase in T47D cells. (1993) (7)
Parathyroid function and serum calcitonin in children receiving anticonvulsant drugs (1980) (7)
Type III hyperlipoproteinemia in a child with hemolytic uremic syndrome. (1990) (7)
The hypercalcemic Walker carcinosarcoma 256 of the rat causes an increase in serum 1,25-dihydroxyvitamin D3. (1989) (7)
THE EFFECT OF CALCITONIN ON ATROPHY AND NEW FORMATION OF BONE (1969) (7)
[Impact of pretreatment variables on the outcome of standardized 131I therapy with 150 Gray in Graves' disease]. (1997) (7)
Risk Factors of Osteoporosis: Results of EVOS in Germany (1996) (6)
[Primary hyperaldosteronism without arterial hypertension]. (2008) (6)
[The effect of calcitonin on experimental osteoporosis in the rat]. (1971) (6)
A new in vitro bioassay for human calcitonin: validation and comparison to the rat hypocalcemia bioassay. (1992) (6)
[Do markers of bone metabolism reflect the presence of a high- or low-turnover state of bone metabolism?]. (2002) (6)
[Vertebral deformity as an index of osteoporosis-induced spinal fracture--an external validity construct based on bone density data]. (1998) (6)
Diminished calcitonin secretion after ovariectomy without apparent reduction in calcitonin content in the rat. (1993) (6)
The Influences of Experimentally Induced Hyper- and Hypocalcaemia on Gastric Function in Rat and Man (1972) (6)
RENAL OSTEODYSTROPHY IN CHILDREN: THERAPY WITH VITAMIN D3 OR 1,25 DIHYDROXY-CHOLECALCIFEROL (1,25-DHCC) (1980) (6)
[Neutralizing antibodies against salmon calcitonin. The cause of a treatment failure in Paget's disease]. (1994) (6)
Chronic hyperinsulinism induced down-regulation of insulin post-receptor signaling transduction in Hep G2 cells (2008) (6)
Evidence in liver for a disulphide-linked scavenger receptor containing a binding site for acetylated low-density lipoprotein and maleylated bovine serum albumin. (1988) (6)
The effects of triiodothyronine on human osteoblast-like cells metabolism and interactions with growth hormone. (2003) (6)
A new role for the low density lipoprotein receptor. (1991) (6)
Evaluation of somatostatin as a plasma tumor marker in medullary thyroid carcinoma. (1995) (6)
Leptin—a parameter for body fat measurement in patients with eating disorders (1998) (5)
Influence of parathyroidectomy, 1,25-dihydroxyvitamin D3 and high dietary calcium intake on demineralized bone matrix powder-induced bone formation in the rat. (1991) (5)
STUDIES ON THE HYPERCALCEMIC SYNDROME IN RATS WITH WALKER CARCINOSARCOMA 256 (1972) (5)
Hypercalcitoninaemia in patients with pheochromocytoma (1978) (5)
The 20210 G to A Prothrombin Polymorphism and Late Complications in Type 1 Diabetes Mellitus (1999) (5)
[Biphosphonate therapy in the management of skeletal metastases]. (1998) (5)
Antiestrogen treatment produces loss of bone mass as a side-effect in the rat (1985) (5)
[Paget's disease of bone: ultrastructure and cytogenesis of osteoclasts (author's transl)]. (1977) (5)
[When should incidentalomas of the adrenal gland be surgically treated?]. (1990) (5)
Importance of early diagnosis and follow-up in multiple endocrine neoplasia (MEN II B) (1984) (5)
Effects of somatostatin on calcitonin and ectopic ACTH release in a patient with medullary thyroid carcinoma (1977) (5)
The effect of calcitonin on disuse atrophy of bone in the rat (2005) (5)
[Clinical features and diagnosis of mild 3-beta-hydroxysteroid dehydrogenase deficiency in men]. (2008) (5)
Rat bone osteolysis in vitro: inhibitory effects of glucagon and cortisol. (1971) (5)
Variations of plasma calcitonin levels measured by radioimmunoassay systems for human calcitonin. (1984) (5)
Alteration of the activity of the 11beta-hydroxysteroid dehydrogenase in pregnancy: relevance for the development of pregnancy-induced hypertension? (2001) (4)
Importance of ultrasound examination in the follow-up of medullary thyroid carcinoma in comparison with other localisation methods (1986) (4)
Changes of bone remodelling surfaces and bone structure in Paget's disease following long-term treatment with calcitonin (1976) (4)
Inflammation-mediated osteopenia (IMO): No change in bone resorption during its development (1991) (4)
URINARY FREE DEOXYPYRIDINOLINE : COMPARISON OF A NEW AUTOMATED CHEMILUMINESCENCE IMMUNOASSAY WITH HPLC AND ELISA TECHNIQUES (1998) (4)
In vitro secretion of calcitonin from a rat C cell line: effect of repetitive stimulation with the calcium channel agonist BAY K 8644. (1992) (4)
Atypical type III hyperlipoproteinemia in a patient with Ig A myelomatosis (1990) (4)
[Tumor markers in C-cell cancer]. (1983) (4)
Treatment of paget's disease of bone with the new bisphosphonate ibandronate (BM 21.0955) by intravenous injection and continuous infusion (1995) (4)
[What is reliable in the treatment of osteoporosis in menopausal women?]. (1993) (4)
Apolipoprotein (a) phenotypes and lipoprotein (a) concentrations in patients with type III hyperlipoproteinaemia (1994) (4)
[Treatment of Paget's deforming osteodystrophy using calcitonin]. (1975) (4)
[The Wolfram syndrome: diabetes mellitus, hypacusis, optic atrophy and short stature in STH deficiency]. (2008) (4)
No advantage of the new combined octreotide‐GHRH test over established GH‐stimulation tests in the diagnosis of growth hormone deficiency (GHD) in adults (2000) (4)
[Katacalcin--a new tumor marker in C-cell cancer of the thyroid gland]. (1987) (4)
Decreased insulin-like growth factors 1 and 2 in sera of patients with osteoporosis (1992) (4)
Activation of Tubular Epithelial Cells in Diabetic (2002) (4)
[3 beta-hydroxysteroid dehydrogenase deficiency and 21-hydroxylase deficiency in hirsutism]. (2008) (4)
Tumor necrosis factor alpha inhibits the stimulatory effect of the parathyroid hormone-related protein on cyclic AMP formation in osteoblast-like cells via protein kinase C+. (1992) (3)
Different effects of hypercalcemic state induced by walker tumor (HWCS 256) and 1,25 (OH)D3 intoxication on rat thyroid C cells (1984) (3)
Effects of 17 beta-estradiol on calcitonin secretion and content in a human medullary thyroid carcinoma cell line. (1991) (3)
[Echographic localization diagnosis of enlarged parathyroid glands]. (1989) (3)
1,25-Dihydroxyvitamin D3 stimulates growth and inhibits calcitonin secretion in a human C cell carcinoma cell line. (1995) (3)
Interactions of calcium, magnesium and atropine on exocrine pancreatic secretion in man (1978) (3)
[On the biological determination of parathormone, using liberation of 32P, by the parathyroidectomized rat under ethanol anesthesia. Methodology, sensitivity, precision]. (1967) (3)
Long-term exposure to SMS 201-995 inhibits proliferation and calcitonin release in neoplastic C-cells. (1993) (3)
Clinical picture of humoral hypercalcemia of malignancy. (1994) (3)
GnRH-agonist therapy alters calcium homoeostasis and reduces bone mineral content (1988) (3)
Effect of glucocorticoid-, parathyroid- and thyroid hormones excess on human iliac crest bone matrix insulin-like growth factor (IGF)-I in patients with osteoporosis. (2009) (3)
In vitro secretion of peptides of the calcitonin family: calcitonin, katacalcin, and calcitonin gene-related peptide. (1987) (3)
The Effect of Exogenous and Endogenous Thyrocalcitonin on Phosphaturia (1968) (3)
[Gastric and exocrine pancreatic function in patients with medullary thyroid carcinoma and with bone diseases under treatment with calcitonin (author's transl)]. (1978) (3)
[Current musculoskeletal symptoms in peri and postmenopausal women: results of a multicenter population epidemiological study. The EVOS Study Group]. (1994) (3)
[PTH-related protein (PTHrP) in serum of patients with tumor hypercalcemia]. (1991) (3)
Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis (1990) (3)
Changing serine-485 to alanine in the opossum parathyroid hormone (PTH)/PTH-related peptide receptor enhances PTH stimulation of phospholipase C in a stably transfected human kidney cell line: a useful model for PTH-analog screening? (2001) (3)
Calcitonin secretion and cyclic AMP-efflux from C-cells, stimulated by glucagon and either calcium or Bay K 8644. (1989) (3)
[Clinical aspects of osteoporosis]. (1990) (3)
Inhibition of Platelet Aggregation and Thromboxane Biosynthesis by the Calcium Antagonist Nisoldipine after Single Oral Administration to Man (1985) (3)
培養内皮細胞でプレプロエンドセリン、組織因子、癌原遺伝子の転写を増強する腫瘍壊死因子カケクチン (1991) (2)
Foreign body granulomatous inflammation increases the sensitivity of splenocytes to immunomodulation by 1,25-dihydroxyvitamin D3. (1993) (2)
[Bisphosphonate therapy of Paget's disease of bone with pamidronate]. (1996) (2)
[What is reliable in therapy of osteoporosis?]. (1990) (2)
The effect of calcitonin on glucose assimilation and insulin secretion in man. (1973) (2)
[Parathyrotoxic crisis with fatal outcome--what can be learned from this?]. (1992) (2)
Bone cells and structure of cancellous bone in primary hyperparathyroidism—A histomorphometric and electron microscopic study (1975) (2)
Changes in the Concentration of Insulin-Like Growth Factor I and Transforming Growth Factor β1 in Rat Femoral Bone during Growth (2014) (2)
[Secondary resistance to coumarin derivatives in a patient with a hypercoagulability syndrome]. (1997) (2)
[Current interdisciplinary diagnosis and therapy of endocrine orbitopathy. Smoking and endocrine orbitopathy]. (1997) (2)
[Effect of metformin on gene expression of phosphoenolpyruvate carboxykinase]. (2002) (2)
[Morphologic changes in iliac crest trabecular bone in primary hyperparathyroidism and their significance for diagnosis]. (1987) (2)
Neuron-specific enolase in medullary thyroid carcinoma: immunohistochemical demonstration, but no significance as serum tumor marker (2004) (2)
Effects of helodermin on fetal rat bone metabolism in vitro. (1990) (2)
Secretion of calcitonin and carcinoembryonic antigen in long-term organ culture of human medullary thyroid carcinoma: Biochemical and immunocytochemical studies (1985) (2)
[Ultimobranchial cells: site of calcitonin formation]. (1968) (2)
[Poisoning danger in high dosage vitamin D therapy of dermatologic diseases]. (1983) (2)
17th Annual Meeting of ISGD (1991) (2)
Crucial role of c-myc in 1,25(OH)2D3 control of C-cell-carcinoma proliferation. (1995) (2)
Increased serum concentration of 1,25(OH)2D3 in hypercalcemia of malignancy: clinical study and animal model (Walker carcinosarcoma 256) (1987) (2)
Idiotypic determinants and antiglobulins in multiple myeloma. (1977) (2)
[Intravascular coagulation in solid Walker carcinosarcoma 256]. (1971) (2)
[Mutations of ret-proto-oncogene in thyroid medullary carcinoma]. (1997) (2)
Synthetic human calcitonin (Cibacalcin, Ciba-Geigy): use for radioimmunoassay and bioassay. (1982) (2)
Type III hyperlipoproteinemia in a patient with idiopathic hemochromatosis (2004) (2)
Effects of endogenous and exogenous calcitonin on inflammation-mediated osteopenia in the rat. (1992) (2)
[Primary hyperparathyroidism. Psychological factors before and after parathyroidectomy]. (1983) (2)
Role of voltage-dependent calcium channels in secretion of calcitonin from human medullary thyroid carcinoma cells (1989) (2)
ENDOKRIN AKTIVE EPITHELKORPERCHENZYSTE : DIAGNOSE DURCH BESTIMMUNG DES INTAKTEN PARATHORMONS IN DER ZYSTENFLUSSIGKEIT (2008) (2)
Primary hyperparathyroidism and multiple endocrine neoplasia (MEN). (1982) (1)
Radiation therapy of non-functioning pituitary tumours - Results of a retrospective study (1987) (1)
[Therapeutic concepts in the treatment of postmenopausal osteoporosis]. (1994) (1)
[Terguride in hyperprolactinemia--experiences with 5 patients]. (1990) (1)
Effects of serum on the calcitonin-dependent bone resorption in vitro. (1973) (1)
Levels of parathyroid hormone-related protein in hypercalcemia of malignancy: comparison of midregional radioimmunoassay and two-site immunoradiometric assay (2004) (1)
The calcitonin receptor: characterization and processing. (1990) (1)
Impact of Pretreatment Variables on the Outcome of [131]I Therapy with a Standardized Dose of 150 Gray in Graves' Disease (1997) (1)
[Endocrinously active parathyroid cysts. Their diagnosis by the determination of intact parathormone in the cyst fluid]. (1992) (1)
[Regulation of the endothelium by TNF]. (1991) (1)
[Hyperthyroidism caused by a hormone-producing follicular thyroid cancer]. (1989) (1)
Calcitonin deficiency is not the mediator of osteopenia in ovariectomized rats (1988) (1)
Transforming growth factor beta (TGF-β) is chemotactic for osteoblast-like cells (1989) (1)
Cerivastatin: A pooled efficacy analysis (1999) (1)
[Hearing disorders in Paget's disease]. (1986) (1)
Inherited thyroxine-binding globulin excess. Study in a kindred. (1986) (1)
Modulation of calcitonin secretion by modification of calcium channels? (1989) (1)
[Bone metabolism and diseases]. (1996) (1)
[Mucosal neuromas of the lips and tongue. Early symptoms of multiple endocrine neoplasia type IIb]. (1986) (1)
[Therapy of osteoporosis using the ADFR schedule (especially with parathyroid hormone and etidronate)]. (1991) (1)
[Diagnostic significance of parathyroid hormone-related protein in tumor patients with hypercalcemia]. (1993) (1)
Interaction of calcitonin gene-related peptide with the calcitonin receptor in fetal rat osteoclasts (1988) (1)
Lipoproteins and their functions (1994) (1)
Bisphosphonate therapy for skeletal metastases (1998) (1)
Somatostatin acts via a pertussis toxin-sensitive mechanism on calcitonin secretion in C-cells. (1992) (1)
[A simple methylmetacrylate embedding for the preparation of thin sections from bones]. (1970) (1)
Calcitonin secretion from a rat C-cell-line: synergistic stimulatory effects of glucagon and calcium, Bay K 8644 or A 23187, respectively (1988) (1)
[The diagnosis and therapy of hypoparathyroidism]. (2008) (1)
[Relations between excretory pancreas function and calcium metabolism in man]. (1972) (1)
Metastatic C-cell carcinoma: Calcitonin and CEA production in monolayer culture (2004) (1)
[Combination therapy with adriamycin, cisplatin and vindesine in C cell carcinoma of the thyroid]. (1990) (1)
[On the question of endocrine side effects in patients on medication for renal calcium stone disease (author's transl)]. (1980) (1)
Notice on Short Communications (1974) (1)
Transforming growth factor beta (TGF-β) increases plasminogen activator (PA) activity in osteoblast-like cell cultures from fetal rat calvariae (1989) (1)
Transforming growth factor β (TGF-β) increases insulin-like factor I (IGF I) secretion in osteoblast-like cells (1989) (1)
Procollagen-III peptide serum levels in Paget's disease of the bone (1987) (1)
[Histomorphometric studies on the influence of long-term calcitonin therapy on osteodystrophia deformans Paget]. (1977) (1)
Do clinicians overestimate the diagnostic usefulness of parathyroid hormone immunoassays? (1984) (1)
[Adrenomyeloneuropathy, a rare cause of primary adrenal cortex insufficiency]. (2008) (1)
Abnormal adrenal androgen secretion in women with "idiopathic" hirsutism: use of ACTH-test (1985) (1)
[Paget's disease of the skeleton]. (1988) (1)
Rapid determination of intact parathyrin in serum in hypercalcemic crisis, based on a commercially available kit. (1990) (1)
COMPARISON OF BIOASSAY AND RADIOIMMUNOASSAY FOR CALCITONIN IN MEDULLARY CARCINOMA OF THE THYROID (1975) (1)
Prolactinoma in multiple endocrine neoplasia type I (1985) (1)
Development and validation of an assay to measure bioactivity of human calcitonin in vitro using T47D cell membranes. (1993) (1)
Diagnostik der Osteoporose: Densitometrie versus Ultraschall (1998) (1)
[On the biological effectiveness of pharmaceutical parathyroid hormone preparations]. (1966) (1)
[Epidemiology of osteoporosis]. (1998) (1)
Physical activity increases bone formation and decreases bone resorption as assessed by biochemical markers of bone turnover (2006) (1)
3.6 Zyanose (2013) (0)
2.W14.4 Tissue factor — role in coagulation and angiogenesis (1997) (0)
The possible role of platelets as trigger in intravascular coagulation associated with acute hyperparathyroidism. (1972) (0)
Internalisation of calcitonin receptor complexes in primary rat kidney cell culture (1988) (0)
[Pathophysiologic mechanisms of atherogenesis with special reference to lipid metabolism]. (1992) (0)
[Thyroid gland diseases: long-term treatment and follow-up]. (1988) (0)
Glucocorticoid receptor mediated upregulation of endothelin-1 receptor gene expression in human osteoblastic cells and its role in the pathogenesis of glucocorticoid-induced osteonecrosis (1999) (0)
2.1 Zyanose (2013) (0)
[Definition of hyperparathyroidism and indication for surgical therapy]. (1999) (0)
Absence of RAGE results in osteopenia (2004) (0)
5.1 Akute Tracheobronchitis (2013) (0)
Down-regulation of different post-receptor signal transduction pathways by chronic insulin stimulation (2003) (0)
2.5 Hiatushernie (2013) (0)
1.25-dihydroxyvitamin D3 mediates the effect of parathyroid hormone on new bone formation in the rat (1988) (0)
4.16 Listeriose (2013) (0)
Calcitonin-biochemistry and physiology. (1976) (0)
[Behavior of gastric secretion in acute EDTA-hypocalcemia in man]. (1971) (0)
Antiandrogen administration reduces bone mass in the male rat (1988) (0)
二甲双胍对磷酸烯醇丙酮酸羧激酶基因表达调节的研究 (2002) (0)
[APC (activated protein C) resistance and oral contraceptives]. (1996) (0)
[Hormone-induced phosphaturia: the effect of parathormone in comparison with other hormones]. (1969) (0)
10.5 Kyphoskoliose (2013) (0)
[Growth factors and cytokines in the pathogenesis of cardiovascular diseases]. (1991) (0)
[Paget's disease of the skeleton. Pathogenesis, diagnosis and therapy]. (1985) (0)
[Mechanism of the hypocalcemic action of glucagon]. (1971) (0)
4.5 Morbus Whipple (Lipodystrophia intestinalis) (2013) (0)
Effects of basic fibroblastic growth factor (bFGF), transforming growth factor beta 1 (TGF-β1) and platelet-derived growth factor-BB (PDGF-BB) on human osteoblastic Sa-Os2 osteosarcoma cells and interactions with triiodothyronine (2000) (0)
Follow-up of Medullary Thyroid Cancer (2001) (0)
Total and peptide bound, but not free pyridinium crosslinks increase with age in healthy subjects (2006) (0)
[Therapy of Paget's disease of bone]. (1988) (0)
Parathyroid hormone enhances osteogenesis in a rat model for extraosseous bone formation (1984) (0)
Calcitonin and thyroid function influence the mineral content of bone in rats (1988) (0)
EVOS: Health Consequences of Vertebral Deformities (1996) (0)
4.3 Hyperventilation (2013) (0)
[Experiences with calcitonin long-term therapy of Paget's disease]. (1975) (0)
Response to therapy of a type III hyperlipoproteinemic subject with the rare apolipoprotein E1 (Gly127 → Asp, Arg158 → Cys) variant (1992) (0)
3.1 Transplantation (2013) (0)
5.2 Leitsymptom: Splenomegalie (2013) (0)
[Rational laboratory diagnosis in endocrinology. Based on recommendations of the German Society of Endocrinology]. (1994) (0)
[Calcitonin determination as a possibility for the evaluation of surgical result in medullary thyroid carcinoma (C-cell carcinoma)]. (1975) (0)
11.9 Pulmonalstenose (2013) (0)
[Adrenal gland tumors from the internist's viewpoint]. (1982) (0)
Paget’s disease of bone: remission and relapse after treatment (1999) (0)
[Primary hyperparathyroidism. Clinical experiences, with special emphasis on selective neck vein catheterization and determination of parathyroid hormone]. (1980) (0)
11.2 Aortenstenose (2013) (0)
[Diagnosis of Paget's disease of bone]. (1988) (0)
[Diagnostic problem of primary hyperparathyroidism in other hypercalcemic diseases]. (1974) (0)
9.1 Definition (2013) (0)
[Treatment of tumor hypercalcemia with clodronate. Effect on parathormone and calcitriol]. (1987) (0)
5.3 Lungenemphysem (2013) (0)
5.1 Definition (2007) (0)
Inflammation-mediated osteopenia: bone loss is not due to osteoclast activation (1988) (0)
Homologous and heterologous desensitization to calcitonin in T47D cells (1989) (0)
Adrenomyeloneuropathy, a rare form of Addison's disease: two case reports (1986) (0)
ELEVATION IN CIRCULATING 1,25-DIHYDROXIVITAMIN D IN A PATIENT WITH T-CELL LYMPHOMA ASSOCIATED HYPERCALCEMIA (1991) (0)
[Excessive hypertriglyceridemia and pancreatitis in a 17-year-old pregnant patient]. (1991) (0)
1.4 Diagnostische Methoden (2013) (0)
Down-regulation of calcitonin receptors in T47D cells by vanadate (1989) (0)
4.3 Leitsymptom (2013) (0)
[Investigations concerning the hypocalcemic effect of glucagon in rats]. (1971) (0)
[Renal osteodystrophy in children. Therapy with 1,25-dihydroxy-cholechalciferol (author's transl)]. (1980) (0)
7.3 Ileus (2013) (0)
Influence of dexamethasone and 1,25-Dihydroxyvitamin D on Walker carcinosarcoma 256 growth and parathyroid hormone-related protein secretion. (1996) (0)
[Influence of hyper- and hypocalcemia on gastric secretion in rats]. (1971) (0)
2.2 Dyspnoe (2013) (0)
6.2 Phlebothrombose (2013) (0)
[Human growth hormone. Its effect on metabolism, hormone metabolism and growth in hypophysial dwarfism]. (1961) (0)
INFLUENCE OF PARATHYROID HORMONE AND CALCITONIN ON THE LIPOLYSIS OF HUMAN ADIPOSE TISSUE (1974) (0)
Comparison of osteoporosis risk assessment using quantitative ultrasound (QUS) measurements of calcaneus, phalanges and tibia (2006) (0)
4.1 Definition (2013) (0)
Adaptation of vitamin D metabolism to calcium challenge: is it dependent on parathyroid hormone? (1989) (0)
Calcitonin-gene-related-peptide acts on calcitonin receptors in a human breast cancer cell line ( T 47 D ) (1987) (0)
9.1 Pneumothorax (2013) (0)
3.3 Lymphadenopathie (2013) (0)
[Therapy of Paget's disease of bone with diphosphonates and calcitonin]. (1978) (0)
Cerivastatin-induced reduction in plasma triglycerides is directly related to baseline levels (1999) (0)
4.4 Bartonellose (2013) (0)
Peptides of the calcitonin family in patients with medullary thyroid carcinoma (1986) (0)
Management of Postoperative Hypoparathyroidism (1986) (0)
27.5 Hypothyreose (2011) (0)
7.2 Akute interstitielle Nephritis (AIN) (2013) (0)
Bone density (BMD), bone markers and IGF’s in glucocorticoid-treated patients (2006) (0)
11.5 Mitralstenose (2013) (0)
[Paget's disease of the skeleton]. (1988) (0)
[Female pseudohermaphroditism in congenital adrenogenital syndrome as an incidental intraoperative finding in a 68 year old patient]. (2000) (0)
Cytokine Induced Stimulation of Endothelial Cells in Vitro (1990) (0)
13.1 Akutes Abdomen (2007) (0)
[On the hypocalcemic effect of endogenous and exogenous thyrocalcitonin in the rat]. (1968) (0)
2.3 Diagnostische Methoden (2013) (0)
[Threshold situations of hyperparathyroidism: ectopic location of adenoma and paraneoplastic secretion of the parathyroid hormone]. (1976) (0)
7.3 Akute Pyelonephritis (2013) (0)
4.6 Brucellosen (2013) (0)
LOCAL INFLAMMATION INCREASES THE INHIBITORY EFFECT OF 1,25- DIHYDROXYVITAMIN D3 ON LYMPHOCYTE ACTIVATION (1991) (0)
Current concepts in the management of pulmonary tuberculosis. (1978) (0)
Effects of ovariectomy on inflammation-mediated osteopenia (IMO) (1989) (0)
[Type III hyperlipoproteinemia in idiopathic hemochromatosis]. (1990) (0)
Isolated Endothelial Cells - A Study in Ex Vivo -- Affected by Tumor Cells and Host Immune Status Identification of Four Genes in Endothelial Cells Whose Expression Is (2013) (0)
Dynamics of osteoclasia in rats with Walker tumor (1976) (0)
The Influence of pamidronate (APD) on hypercalcemia, tumor growth and PTHrP-Secretion in the Walker Carcinosarcoma 256 in rats (1995) (0)
Influences of Endogenous Parathyroid Hormone upon Development and Treatment (Calcium, Calcitonin, Sodium Fluoride) of Experimental Bone Atrophy (1975) (0)
[Paget's osteitis deformans. Significance and control]. (1984) (0)
4.8 Adrenogenitales Syndrom (AGS) (2013) (0)
[Pyridinium cross-links in the urine. Specific markers of bone resorption in metabolic bone diseases]. (1994) (0)
[Paget's disease of bone]. (2019) (0)
[Calcitonin and gastric secretion: various effects of calcitonin on acid and pepsin secretion during stimulation with pentagastrin, betazol and insulin hypoglycemia]. (1974) (0)
[The antibaby pill as a risk factor for thrombosis: are the molecular mechanisms known?]. (1991) (0)
[Endocrine diagnosis of medullary thyroid carcinoma]. (1978) (0)
Interaction of acetyl-LDL and Mal-BSA with scavenger receptor sites of rat liver. (1988) (0)
[Interrelations between gastrointestinal hormones and endocrine regulation]. (1976) (0)
2.4 Cholestase (2013) (0)
1.1 Definition (2013) (0)
PARATHYROID HORMONE IN HUMAN TISSUES (1983) (0)
Parathyroid function and serum calcitonln in children receiving phenytoin drugs: 47 (1980) (0)
Table of Contents (1987) (0)
Stimulation of calcitonin secretion in vitro by the calcium channel agonist BAY K 8644 in rat thyroid tissue and human medullary thyroid carcinoma tissue (1987) (0)
Vascular Origin ofKaposi's Sarcoma Expression ofLeukocyte Adhesion Molecule-1, Thrombomodulin, andTissue Factor (1994) (0)
Tumor-associated osteopenia (RAT): Influence of osteolytic tumor factors and tumor-host-reaction (1986) (0)
[Osteo-anabolic estrogen therapy in a transsexual man]. (1999) (0)
[Generalised paraneoplastic calcinosis due to the Walker-carcinosarcoma of the rat (author's transl)]. (1971) (0)
[Parathormone determination with synthetic human parathormone 1-34 (PTH) (author's transl)]. (1975) (0)
DECREASE OF PLASMA 1,25-DIHYDROXYVITAMIN D3 (1,25(OH)2D3) AND LOSS OF SPINAL BONE MASS IN WOMEN DURING TREATMENT WITH GnRH AGONISTS. (1988) (0)
[Treatment strategies for parathyroid neoplasms]. (1988) (0)
[Etidronic acid therapy in Paget's disease of bone]. (1983) (0)
4.4 Glutensensitive Enteropathie (2013) (0)
[Swelling of the breast gland in puberty]. (1996) (0)
[Cardiomyopathy in hypocalcemia]. (1989) (0)
[Bone metabolism and disorders]. (1996) (0)
2.2 Spondyloarthritiden (SpA) (2013) (0)
6.2 Aspergillose (2013) (0)
[Therapy of Paget's disease with bisphosphonate pamidronate (AHPrBP, formerly APD)]. (1991) (0)
An increase in external calcium causes intracellular free calcium to oscillate in glucagon-stimulated rat medullary thyroid carcinoma cells (rMTC-cells). A study of Ca-fluctuations in single cells (1989) (0)
Radiotherapy for Vaginal Bleeding Caused by Advanced Pelvic Neoplasms: Review of the Literature and Eight Own Cases (2009) (0)
[Changes in thyroxine-binding globulin: pitfalls in thyroid function diagnosis]. (2008) (0)
4.3 Myeloproliferative Neoplasien (MPN) (2013) (0)
Enhanced suppression of 1,25(OH)2D3 levels in Graves' disease (GD) as compared to toxic nodular goiter (TNG) independent of T3 elevations: A pathogenetic relationship? (1984) (0)
11.2 Nierentransplantation (NTX) (2013) (0)
Effects of GnRH Agonist-Induced Ovarian Suppression on Calcium Homeostasis and Bone Metabolism in Premenstrual Women (1990) (0)
[Radioimmunologic determination of gastrin, calcitonin, and parathormone. Methods and clinical use]. (1976) (0)
Normal GH-, PICP-and ICTP- and decreased PTH-24 hour-secretion in Osteoporosis (2006) (0)
[Thoracic pain in a power athlete]. (1997) (0)
[Hyperparathyroidism: pathology, diagnosis and therapy]. (1992) (0)
[On the effect of thyrocalcitonin on phosphaturia]. (1967) (0)
A new radioimmunoassay for bone sialoprotein in serum, a potential marker of bone turnover (2006) (0)
The radioimmunological determination of calcitonin. Introduction to the discussion. (1971) (0)
2.5 Ödeme (2013) (0)
2.2 Diagnostische Methoden (2013) (0)
1.5 Geriatrische Rehabilitation (2013) (0)
[Internal medicine aspects of endocrine tumors. The hypophysis, epithelial bodies and adrenal glands]. (1989) (0)
Altered vitamin D metabolism in rats with the hypercalcemic walkercarcinosarcoma 256 (1987) (0)
Vascular and Neural Complications (1998) (0)
Osteodystrophia deformans Paget (1979) (0)
Bone Ceils and Structure of Cancellous Bone in Primary Hyperpara- thyroidism-A Histomorphometric and Electron Microscopic Study (0)
Osteoporosis will never be a disease of the past (2005) (0)
Inherited Thyroxine-Binding Globuline Excess (2009) (0)
Regulation of 1,25-dihydroxyvitamin D3 by estrogen via bone matrix constituents (1989) (0)
Monensin blocks processing of the calcitonin-receptor complex in T 47 D cells (1987) (0)
Antithyroid drug treatment of von Basedow's disease: results from a multicenter study. (2009) (0)
Influential factors in bone mineral density and bone metabolism in type II diabetes mellitus (2006) (0)
The antihypercalcemic action of gallium-nitrate is not due to inhibition of parathormone or parathormone-related protein secretion in rats (1997) (0)
Differential Treatment of Osteoporosis with Medicaments (2015) (0)
1.11 Leberzirrhose (2013) (0)
Clinical variability of 3β-hydroxysteroid dehydrogenase deficiency and 21-hydroxylase deficiency in males (1987) (0)
[EMG and evoked potentials in adrenomyeloneuropathy]. (1985) (0)
Can the routine treatment of Graves' orbitopathy be efficiently supplemented by the administration of Venalot? (1989) (0)
4.15 Leptospirosen (2013) (0)
6.2 Transfusionstherapie (2013) (0)
Diagnostic value of osteocalcin levels in patients with primary hyperparathyroidism (1986) (0)
[Systemic lupus erythematosus as a contraindication for estrogen treatment]. (1994) (0)
[Drug treatment of osteoporosis (in the woman)]. (1998) (0)
[Primary hyperparathyroidism]. (1989) (0)
7.10 Kardiopulmonale Reanimation (2013) (0)
28. Primärer und sekundärer Hyperparathyreoidismus (1979) (0)
[The prognostic importance of calcitonin screening in familial medullary thyroid carcinoma]. (1993) (0)
Experimental study on bone of parathyroidectomized rats (2008) (0)
23.3 Kollagenosen (2011) (0)
5.3 Pathogenese (2013) (0)
5.4 Enterokolitiden (2013) (0)
Interlaboratory Comparison of Radioimmunolo gical Calcitonin Determination1) (1982) (0)
The serum concentration of insulin-like growth factor binding protein-5 (IGFBP-5) is related to vitamin D status in patients with osteoporosis (1995) (0)
[Lipoprotein(a) [Lp(a)]--a genetically related risk factor for arteriosclerosis]. (1994) (0)
Effects of donor age and bone volume on DNA synthesis of human osteoblast-like cells in vitro (1992) (0)
1.3 Leitsymptome (2013) (0)
[Interaction between gastrointestinal hormones and endocrine regulation]. (1976) (0)
7.2 Akute Appendizitis (2013) (0)
[The determination of calcitonin for hospital use (author's transl)]. (1977) (0)
[Oral contraceptives as risk factors for vascular disease: what is known about the molecular mechanism?] (1991) (0)
13.3 Schock (2013) (0)
9.4 Pathogenese (2013) (0)
Effect of repetitive stimulation by calcium and Bay K 8644 on calcitonin secretion (1989) (0)
[Origin, clinical aspects and therapy of Paget's disease of bone]. (1989) (0)
[Paget disease of the skeleton. Internal medicine aspects]. (1984) (0)
[Hypercalcemia caused by generalized sarcoidosis]. (2000) (0)
2.7 Obstipation (2013) (0)
1,25(OH)2D3 MEDIATES THE EFFECT OF PARATHYROID HORMONE ON NEW BONE FORMATION IN THE RAT (1988) (0)
90066279 A study of complaints and their relation to vertebral destruction in patients with osteoporosis (1990) (0)
6.3 Thrombophlebitis (2013) (0)
[Endocrinopathies of calcium metabolism]. (1982) (0)
[Excretory pancreatic function in the rat: inhibition by high doses of CCK pancreozymin and anesthesia]. (1973) (0)
[Extraosseous calcification in juvenile dermatomyositis. The ineffectiveness of EHDP]. (1988) (0)
4.9 Cholera (2013) (0)
[Osteoporosis in the male]. (2000) (0)
2.9 Invasive Methoden (2013) (0)
5.3 Reizdarmsyndrom (RDS) (2013) (0)
5.6 Prognose (2013) (0)
Typ-III-Hyperlipoproteinämie bei sekundärer Hypothyreose (1990) (0)
[Parathyroid carcinoma]. (2020) (0)

This paper list is powered by the following services:

Reinhard Ziegler's Academic­Influence.com Rankings

Reinhard Ziegler's Degrees

Why Is Reinhard Ziegler Influential?

Reinhard Ziegler's Published Works

Published Works

Reinhard Ziegler's AcademicInfluence.com Rankings